A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2016.5058
Abstract: A Novel Alternate Dosing of Vismodegib for Treatment of Patients With Advanced Basal Cell Carcinomas Basal cell carcinoma (BCC) is the most common cutaneous malignancy with a favorable prognosis, as the estimated cure rate when… read more here.
Keywords: dosing vismodegib; patients advanced; basal; basal cell ... See more keywords
Development of a Machine Learning Model for Survival Risk Stratification of Patients With Advanced Oral Cancer
Sign Up to like & getrecommendations! Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.11768
Abstract: Key Points Question Can a machine learning model provide survival risk stratification for patients with advanced oral cancer who have comprehensive clinicopathologic and genetic data? Findings In this 15-year cohort study of 334 patients, a… read more here.
Keywords: patients advanced; risk stratification; advanced oral; model ... See more keywords
Transportability of Overall Survival Estimates From US to Canadian Patients With Advanced Non–Small Cell Lung Cancer With Implications for Regulatory and Health Technology Assessment
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.39874
Abstract: Key Points Question Is overall survival of patients with advanced non–small cell lung cancer (NSCLC) that is estimated from US-based clinical practice data externally valid among Canadian patients who receive the same systemic therapies? Findings… read more here.
Keywords: non small; survival; patients advanced; small cell ... See more keywords
Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant Melanoma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.46400
Abstract: Key Points Question What is the association between immune-related adverse events (irAEs) and survival after immune checkpoint inhibitor (ICI) therapy initiation and human leukocyte antigen genes in patients with advanced malignant melanoma? Findings In this… read more here.
Keywords: advanced malignant; patients advanced; immune related; related adverse ... See more keywords
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2022.3395
Abstract: This randomized clinical trial assesses whether etoposide plus cisplatin or irinotecan plus cisplatin is a more effective treatment regimen in terms of overall survival in patients with advanced neuroendocrine carcinoma of the digestive system. read more here.
Keywords: advanced neuroendocrine; patients advanced; cisplatin irinotecan; digestive system ... See more keywords
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.5041
Abstract: Importance Management of checkpoint inhibitor-induced immune-related adverse events (irAEs) is primarily based on expert opinion. Recent studies have suggested detrimental effects of anti-tumor necrosis factor on checkpoint-inhibitor efficacy. Objective To determine the association of toxic… read more here.
Keywords: advanced melanoma; patients advanced; management; line ... See more keywords
Central network changes in patients with advanced monocular blindness: A voxel‐based morphometric study
Sign Up to like & getrecommendations! Published in 2019 at "Brain and Behavior"
DOI: 10.1002/brb3.1421
Abstract: To study the changes in gray matter volume (GMV) in patients with advanced monocular blindness (MB) using voxel‐based morphometry (VBM). read more here.
Keywords: study; advanced monocular; voxel based; patients advanced ... See more keywords
Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2094
Abstract: Studies have rarely explored the efficacy of S‐1 in treating advanced pancreatic cancer outside Japan. This study compared the survival outcomes of patients with advanced pancreatic cancer treated with S‐1 with the survival outcomes of… read more here.
Keywords: patients advanced; survival outcomes; advanced pancreatic; pancreatic cancer ... See more keywords
Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster‐randomized controlled trial in patients with advanced cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4565
Abstract: Early palliative care (EPC) improves the quality of life but may not be feasible for all patients with advanced cancer. Symptom screening has been suggested to triage patients for EPC, but scant evidence exists for… read more here.
Keywords: patients advanced; palliative care; early palliative; advanced cancer ... See more keywords
Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5147
Abstract: Gemcitabine has shown clinical activity against angiosarcoma in small series, alone, or combined with taxanes. We aimed to evaluate its activity as a single‐agent in a larger series of patients with advanced angiosarcoma. We retrospectively… read more here.
Keywords: single agent; patients advanced; agent gemcitabine; gemcitabine ... See more keywords
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5574
Abstract: Fragmented and complex healthcare systems make it difficult to provide continuity of care for patients with advanced cancer near the end of life. Nurse‐based cross‐sectoral navigation support has the potential to increase patients' quality of… read more here.
Keywords: health; patients advanced; advanced cancer; care ... See more keywords